You are not authorized to access this page.
Search Within

Christopher A Famulare

Formats
  1. Meeting Abstract (49)
  2. Journal Article (33)
  3. Research Letter (7)
Groups
  1. Center for Hematologic Malignancies (89)
  2. Department of Medicine (86)
  3. Hematologic Malignancies, Division of (86)
  4. Adult Leukemia (84)
  5. Hematology-Oncology Fellows (63)
  6. Weinberg Fellows (59)

More Groups

People
  1. Ross Levine (48)
  2. Martin Tallman (40)
  3. Aaron Goldberg (38)
  4. Eytan Stein (31)
  5. Mikhail Roshal (28)
  6. Minal Patel (27)

More People

Years
  1. 2025 (6)
  2. 2024 (4)
  3. 2023 (10)
  4. 2022 (4)
  5. 2021 (11)
  6. 2020 (14)

More Years

Publications
  1. Blood (49)
  2. Blood Advances (6)
  3. American Journal of Hematology (4)
  4. Cancer Discovery (4)
  5. Leukemia and Lymphoma (3)
  6. Laboratory Investigation (2)

More Publications

Publishers
  1. American Society of Hematology (55)
  2. Nature Publishing Group (10)
  3. American Association for Cancer Research (5)
  4. John Wiley & Sons, Inc. (4)
  5. Taylor & Francis Group (3)
  6. Cell Press (2)

More Publishers

Results (89)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • CD33 splice site genotype was not associated with outcomes of patients receiving the anti-CD33 drug conjugate SGN-CD33A
    Research Letter

    Stanchina, M.; Pastore, A.; Devlin, S.; Famulare, C.; Stein, E.; Taylor, J.
    Journal of Hematology & Oncology (2019)

    Fulltext@MSK | Save
  • Aurora kinase A inhibition provides clinical benefit, normalizes megakaryocytes, and reduces bone marrow fibrosis in patients with myelofibrosis: A phase I trial
    Journal Article

    Gangat, N.; Marinaccio, C.; Swords, R.; Watts, J. M.; Gurbuxani, S.; Rademaker, A.; Fought, A. J.; Frankfurt, O.; Altman, J. K.; Wen, Q. J.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Loss of plasmacytoid dendritic cell differentiation is highly predictive for post-induction measurable residual disease and inferior outcomes in acute myeloid leukemia
    Journal Article

    Xiao, W.; Goldberg, A. D.; Famulare, C. A.; Devlin, S. M.; Nguyen, N. T.; Sim, S.; Kabel, C. C.; Patel, M. A.; McGovern, E. M.; Patel, A.; more...
    Haematologica (2019)

    Fulltext@MSK | Save
  • Impact of high-molecular-risk mutations on transplantation outcomes in patients with myelofibrosis
    Journal Article

    Tamari, R.; Rapaport, F.; Zhang, N.; McNamara, C.; Kuykendall, A.; Sallman, D. A.; Komrokji, R.; Arruda, A.; Najfeld, V.; Sandy, L.; more...
    Biology of Blood and Marrow Transplantation (2019)

    Fulltext@MSK | Save
  • Small-molecule targeting of MUSASHI RNA-binding activity in acute myeloid leukemia
    Journal Article

    Minuesa, G.; Albanese, S. K.; Xie, W.; Kazansky, Y.; Worroll, D.; Chow, A.; Schurer, A.; Park, S. M.; Rotsides, C. Z.; Taggart, J.; more...
    Nature Communications (2019)

    Fulltext@MSK | Save
  • Mutant and wild-type isocitrate dehydrogenase 1 share enhancing mechanisms involving distinct tyrosine kinase cascades in cancer
    Journal Article

    Chen, D.; Xia, S.; Wang, M.; Lin, R.; Li, Y.; Mao, H.; Aguiar, M.; Famulare, C. A.; Shih, A. H.; Brennan, C. W.; more...
    Cancer Discovery (2019)

    Fulltext@MSK | Save
  • PHF6 mutations are mutually exclusive to TP53 mutations, and define a distinct subgroup of secondary acute myeloid leukemia associated with a primitive stem/progenitor immunophenotype, absent complex karyotype and relatively better outcomes
    Meeting Abstract

    Xiao, W.; Goldberg, A. D.; Ball, B.; Famulare, C.; Pastore, F.; Tallman, M. S.; Zhang, Y.; Arcila, M. E.; Papaemmanuil, E.; Levine, R. L.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Loss of plasmacytoid dendritic cell differentiation is highly predictive for persistent measurable residual disease and poor outcomes in acute myeloid leukemia
    Meeting Abstract

    Xiao, W.; Goldberg, A. D.; Famulare, C.; Delvin, S.; Patel, M.; McGovern, E.; Patel, A.; Schulman, J.; Dunbar, A.; Epstein-Peterson, Z. D.; more...
    Blood (2018)

    Fulltext@MSK | Save
  • Myeloproliferative neoplasm (MPN) blastic transformation occurs at the level of hematopoietic stem cells
    Meeting Abstract

    Wang, X.; Hu, C. S.; Tripodi, J.; Najfeld, V.; Petersen, B.; Rampal, R. K.; Farnoud, N.; Famulare, C.; Mascarenhas, J.; Hoffman, R.
    Blood (2018)

    Fulltext@MSK | Save
  • Comparison of induction strategies and responses for acute myeloid leukemia patients after resistance to hypomethylating agents for antecedent myeloid malignancy
    Meeting Abstract

    Talati, C.; Goldberg, A. D.; Przespolewski, A.; Chan, O.; Al Ali, N.; Famulare, C.; Sallman, D. A.; Padron, E.; Kuykendall, A.; List, A. F.; more...
    Blood (2018)

    Fulltext@MSK | Save